Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTFK1JQ)

• DTT Name: Voltage-gated calcium channel alpha-2/delta-1 (CACNA2D1) DTT Info
• Gene Name: CACNA2D1

Molecule-Related Drug & Molecule List

6 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Amlodipine	DMBDAZV	Angina pectoris	BA40	Approved	[1]
Diltiazem	DMAI7ZV	Angina pectoris	BA40	Approved	[2]
Lercanidipine	DMPWSEM	Hypertension	BA00-BA04	Approved	[3]
Nitrendipine	DM21C09	Hypertension	BA00-BA04	Approved	[4]
Pregabalin	DMDVP3B	Chronic obstructive pulmonary disease	CA22	Approved	[5]
Mirogabalin	DM5GIWZ	Peripheral neuropathy	8C0Z	Registered	[6]

1 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Imagabalin	DMRLVUD	Generalized anxiety disorder	6B00	Phase 3	[7]

1 Discontinued Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
NP-118809	DM8A64W	Pain	MG30-MG3Z	Discontinued in Phase 2	[8]

54 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
(R)-3-(aminomethyl)-4-(furan-2-yl)butanoic acid	DM2DVNT	Discovery agent	N.A.	Investigative	[9]
(S)-2-amino-2-cyclohexylacetic acid	DMVD05E	Discovery agent	N.A.	Investigative	[10]
(S)-2-amino-2-o-tolylacetic acid	DMG9KMN	Discovery agent	N.A.	Investigative	[10]
(S)-2-amino-2-p-tolylacetic acid	DMCDZ8A	Discovery agent	N.A.	Investigative	[10]
(S)-2-amino-2-phenylpropanoic acid	DM2104G	Discovery agent	N.A.	Investigative	[10]
(S)-2-amino-3-(benzylthio)propanoic acid	DM6OUW0	Discovery agent	N.A.	Investigative	[10]
(S)-2-amino-3-cyclohexylpropanoic acid	DM1GBX8	Discovery agent	N.A.	Investigative	[10]
(S)-2-amino-4-(benzylthio)butanoic acid	DMF8I2W	Discovery agent	N.A.	Investigative	[10]
(S)-3-(aminomethyl)-4-(furan-2-yl)butanoic acid	DMTBG57	Discovery agent	N.A.	Investigative	[9]
(S)-phenylglycine	DMAI1HU	Discovery agent	N.A.	Investigative	[10]
1-benzhydryl-4-(3,3-diphenylpropyl)piperazine	DMTYKMR	Discovery agent	N.A.	Investigative	[8]
1-benzhydryl-4-(4,4-diphenylbutyl)piperazine	DM5SWL7	Discovery agent	N.A.	Investigative	[8]
2-(1-(aminomethyl)-3-butylcyclopentyl)acetic acid	DMFXDY3	Discovery agent	N.A.	Investigative	[11]
2-(1-(aminomethyl)-3-ethylcyclopentyl)acetic acid	DM1ASK6	Discovery agent	N.A.	Investigative	[11]
2-amino-2-(2,3-difluorophenyl)acetic acid	DMWDENZ	Discovery agent	N.A.	Investigative	[10]
2-amino-2-(2,4-difluorophenyl)acetic acid	DMSAFUK	Discovery agent	N.A.	Investigative	[10]
2-amino-2-(2-fluorophenyl)acetic acid	DMLXOHE	Discovery agent	N.A.	Investigative	[10]
2-amino-2-(3-bromophenyl)acetic acid	DMEX6AM	Discovery agent	N.A.	Investigative	[10]
2-amino-2-(3-chloro-4-fluorophenyl)acetic acid	DMMU1CQ	Discovery agent	N.A.	Investigative	[10]
2-amino-2-(3-chlorophenyl)acetic acid	DMPZX8U	Discovery agent	N.A.	Investigative	[10]
2-amino-2-(thiophen-2-yl)acetic acid	DMHQNZD	Discovery agent	N.A.	Investigative	[10]
2-amino-4-(2-methyl-benzylsulfanyl)-butyric acid	DMULSNQ	Discovery agent	N.A.	Investigative	[10]
3-(aminomethyl)-4-(furan-2-yl)butanoic acid	DM5497S	Discovery agent	N.A.	Investigative	[9]
3-(aminomethyl)-4-(furan-3-yl)butanoic acid	DMG3FPJ	Discovery agent	N.A.	Investigative	[9]
3-(aminomethyl)-4-(thiophen-2-yl)butanoic acid	DMT72FB	Discovery agent	N.A.	Investigative	[9]
3-(aminomethyl)-4-(thiophen-3-yl)butanoic acid	DMWO1Z7	Discovery agent	N.A.	Investigative	[9]
3-Aminomethyl-5-methyl-hexanoic acid	DMTYXH1	Discovery agent	N.A.	Investigative	[12]
4-(2,3-dichlorobenzylthio)-2-aminobutanoic acid	DMGOHSF	Discovery agent	N.A.	Investigative	[10]
4-(2,5-dichlorobenzylthio)-2-aminobutanoic acid	DMKVH90	Discovery agent	N.A.	Investigative	[10]
4-(2-bromobenzylthio)-2-aminobutanoic acid	DMZ9TSR	Discovery agent	N.A.	Investigative	[10]
4-(2-cyanobenzylthio)-2-aminobutanoic acid	DM82D9N	Discovery agent	N.A.	Investigative	[10]
4-(2-methoxybenzylthio)-2-aminobutanoic acid	DMNSKXR	Discovery agent	N.A.	Investigative	[10]
4-(2-nitrobenzylthio)-2-aminobutanoic acid	DMC1KEG	Discovery agent	N.A.	Investigative	[10]
4-(3,4-dichlorobenzylthio)-2-aminobutanoic acid	DMBEA23	Discovery agent	N.A.	Investigative	[10]
4-(3,4-dimethylbenzylthio)-2-aminobutanoic acid	DM5ZTXO	Discovery agent	N.A.	Investigative	[10]
4-(3,5-dichlorobenzylthio)-2-aminobutanoic acid	DMM3F9K	Discovery agent	N.A.	Investigative	[10]
4-(3,5-dimethylbenzylthio)-2-aminobutanoic acid	DM9MIQB	Discovery agent	N.A.	Investigative	[10]
4-(3-bromobenzylthio)-2-aminobutanoic acid	DML3VB7	Discovery agent	N.A.	Investigative	[10]
4-(3-chlorobenzylthio)-2-aminobutanoic acid	DMQVXMZ	Discovery agent	N.A.	Investigative	[10]
4-(3-cyanobenzylthio)-2-aminobutanoic acid	DMSUB8D	Discovery agent	N.A.	Investigative	[10]
4-(3-fluorobenzylthio)-2-aminobutanoic acid	DMXLC94	Discovery agent	N.A.	Investigative	[10]
4-(3-methoxybenzylthio)-2-aminobutanoic acid	DMTPL0C	Discovery agent	N.A.	Investigative	[10]
4-(3-nitrobenzylthio)-2-aminobutanoic acid	DM4WI0Y	Discovery agent	N.A.	Investigative	[10]
4-(4-bromobenzylthio)-2-aminobutanoic acid	DMHWIMO	Discovery agent	N.A.	Investigative	[10]
4-(4-chlorobenzylthio)-2-aminobutanoic acid	DMENLUP	Discovery agent	N.A.	Investigative	[10]
4-(4-tert-butylbenzylthio)-2-aminobutanoic acid	DMG6DV9	Discovery agent	N.A.	Investigative	[10]
ETHIONINE	DMGESUH	Discovery agent	N.A.	Investigative	[10]
Gababutin	DMDEAWS	Discovery agent	N.A.	Investigative	[11]
N'-Acridin-9-yl-N,N-diethyl-butane-1,4-diamine	DM1XH8D	Discovery agent	N.A.	Investigative	[13]
N,4-dibenzhydrylpiperazine-1-carboxamide	DMOG37L	Discovery agent	N.A.	Investigative	[8]
PD-144550	DM03526	Discovery agent	N.A.	Investigative	[12]
Rac-2-amino-4-phenylbutanoic acid	DMTUR6C	Discovery agent	N.A.	Investigative	[10]
Rac-2-amino-5-cyclohexylpentanoic acid	DMU0746	Discovery agent	N.A.	Investigative	[10]
Trans-dimethyl gababutin	DM8E9YS	Discovery agent	N.A.	Investigative	[14]

References

• [1] A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge. Rev Med Liege. 2007 Nov;62(11):688-94.
• [2] Egr-1, the potential target of calcium channel blockers in cardioprotection with ischemia/reperfusion injury in rats. Cell Physiol Biochem. 2009;24(1-2):17-24.
• [3] Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):981-7.
• [4] Sulfobutyl ether-alkyl ether mixed cyclodextrin derivatives with enhanced inclusion ability. J Pharm Sci. 2009 Dec;98(12):4769-80.
• [5] Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons. Mol Pharmacol. 2006 Aug;70(2):467-76.
• [6] Efficacy and safety of mirogabalin (DS-5565) for the treatment of diabetic peripheral neuropathic pain: a randomized, double-blind, placebo- and active comparator-controlled, adaptive proof-of-concept phase 2 study. Diabetes Care. 2014 Dec;37(12):3253-61.
• [7] Methodology for rapid measures of glutamate release in rat brain slices using ceramic-based microelectrode arrays: basic characterization and drug pharmacology. Brain Res. 2011 Jul 15;1401:1-9.
• [8] Scaffold-based design and synthesis of potent N-type calcium channel blockers. Bioorg Med Chem Lett. 2009 Nov 15;19(22):6467-72.
• [9] Heteroaromatic side-chain analogs of pregabalin. Bioorg Med Chem Lett. 2006 May 1;16(9):2329-32.
• [10] Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41.
• [11] Synthesis and in vivo evaluation of 3-substituted gababutins. Bioorg Med Chem Lett. 2010 Jan 1;20(1):362-5.
• [12] Enantioselective synthesis of PD144723: a potent stereospecific anticonvulsant, Bioorg. Med. Chem. Lett. 4(6):823-826 (1994).
• [13] N-Acridin-9-yl-butane-1,4-diamine derivatives: high-affinity ligands of the alpha2delta subunit of voltage gated calcium channels. Bioorg Med Chem Lett. 2004 Apr 19;14(8):1913-6.
• [14] Synthesis and in vivo evaluation of bicyclic gababutins. Bioorg Med Chem Lett. 2010 Jan 15;20(2):461-4.